The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
about
Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge.Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract.Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications.Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylationPrognostic factors in transitional cell carcinoma of the upper urinary tract after radical nephroureterectomyUreteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinomaHigh expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.The effect of intravesical chemotherapy in the prevention of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma.Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial CarcinomaA comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.Characteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patients.Development and progression of urothelial carcinoma.Androgen receptor decreases the cytotoxic effects of chemotherapeutic drugs in upper urinary tract urothelial carcinoma cellsUpper urinary tract recurrence following radical cystectomy for bladder cancer.Bladder cancer following upper tract urothelial carcinoma.Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder.Trends of adult primary malignant renal tumors overĀ 6 years.Urinary tract cancers: An overview for general practiceManagement of upper urinary tract urothelial carcinoma.Minimally invasive approach in the management of upper- urinary-tract tumours.Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma.Long-term follow-up of patients with tumours of the renal pelvis and ureter: how often is a bladder tumour diagnosed after five tumour-free years?Long-term outcomes of complete urinary tract exenteration for dialysis patients with urothelial cancer.The role of laparoscopy-assisted renal autotransplantation in the treatment of primary ureteral tumor.The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells.Treatment strategies for upper tract urothelial carcinoma (UTUC) of a solitary kidney: a single-institutional analysis of 61 cases.Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer.Shorter hemodialysis duration is a risk factor for the recurrence of urothelial carcinoma of the bladder in patients on maintenance hemodialysis.Severity of hydronephrosis correlates with tumour invasiveness and urinary bladder recurrence of ureteric cancer.Bladder recurrence after radical nephroureterectomy: predictors and impact on oncological outcomes.Diagnostic ureteroscopy independently correlates with intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers.Survival after nephroureterectomy for upper tract urothelial carcinoma: a population-based competing-risks analysis.Long-term outcome of radical cystectomy in ESDR patients with bladder urothelial carcinoma.Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis.Influence of body mass index on oncological outcomes in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
P2860
Q34080219-91C5005B-1C15-421E-B111-D03E2DA35311Q34253712-BE1D732D-7A85-43C6-9A8F-126317A64B75Q34452391-02FED575-03A9-40F4-A69B-A740BAA41632Q34459606-C0BE82C4-7E91-4A22-B2BD-EAB218FFDF03Q35017773-F35A8837-B0E5-499D-8315-D33F12831B8AQ35019593-06F2653B-9919-40E9-9D6A-1EF920206CB2Q35271198-86BECA42-8228-446C-A8B1-19FCA759A761Q35609624-17877FD8-029B-420C-84ED-146483E60BFFQ35629317-49A43ED0-418B-4D80-A03E-AB1E0542E640Q35801387-77F68A97-DCC7-4E68-B953-3CBDF7EBC7B8Q35837779-4473E619-6ABA-4B98-B251-8AD13D6CFA16Q36082104-3109DF25-EE3C-49A6-A897-9D33D3F0C1B3Q36361826-DB953FBD-8D08-4C2B-9907-F8A2CCE943CEQ36527765-93151F28-D2AD-4B2B-BF98-09F9948FDEC4Q36774380-BD6D5294-CBA3-4637-A864-FE22ACBCAE6EQ36860951-5E871D79-24EA-43D4-A501-54E8FE8BA01EQ37038905-326AAAB3-240F-4D87-A939-093DB52108E9Q37152820-BB41D9AC-E8E8-402B-9F4A-191CDDC118CDQ37526944-BAE904FC-1479-41E8-9CFD-9DF7226513E9Q37623193-E950B4DA-679B-4B31-92AE-8EF595F84979Q37812609-596AB821-3BC0-4C01-970C-783034635EF4Q37954409-419B43EB-B258-41CF-BDA6-A1B0B6AB101AQ38007104-9A2E0507-0259-4905-81FC-D75BD5910FF7Q38123892-B998E3FD-23C8-4DC2-BAD3-20F2DF0095E9Q38978623-8B7FA031-319A-451D-B5D7-E6206B463439Q39198521-F2A97032-A318-437F-836E-80A04C08ED51Q39304455-B0618A7E-0C52-468D-A186-12B87B7D45E3Q39633407-2640206E-2FC9-4F32-803A-C914617F4FE7Q39904893-596E633B-B795-47A4-BB4E-FFA955092888Q41537131-CFAC4552-FD48-41E7-83BE-9DCB5F5F4158Q43482972-C331A26C-BE43-4575-89BC-497C0DC7B2B5Q44211301-8BB8C5A3-2B80-4188-8CE5-557BE82423BBQ44212351-E84C2411-F0CF-4998-BB15-2F2F3228032FQ44654146-CC840E39-6C62-423B-9B55-345466BFD5ECQ44979591-0DFD816E-EFEE-448B-89E0-7B90C59A10E0Q45913209-61B7BC4A-DF8C-450F-A8FE-F66770DACFF8Q46465116-1BDB3797-3B90-4E08-A4A7-31668B9F12CFQ48185781-7C866D0D-9B66-4B47-975E-37BDE2413D4CQ50784081-EDA07602-7478-4D9C-A787-AB0274152EBBQ51100757-982FDAA6-C330-4842-80AC-CF73BA44E633
P2860
The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
description
2003 nĆ® lÅ«n-bĆ»n
@nan
2003幓ć®č«ę
@ja
2003幓å¦ęÆęē«
@wuu
2003幓å¦ęÆęē«
@zh
2003幓å¦ęÆęē«
@zh-cn
2003幓å¦ęÆęē«
@zh-hans
2003幓å¦ęÆęē«
@zh-my
2003幓å¦ęÆęē«
@zh-sg
2003幓åøč”ęē«
@yue
2003幓åøč”ęē«
@zh-hant
name
The development of bladder tum ...... ma of the upper urinary tract.
@en
The development of bladder tum ...... ma of the upper urinary tract.
@nl
type
label
The development of bladder tum ...... ma of the upper urinary tract.
@en
The development of bladder tum ...... ma of the upper urinary tract.
@nl
prefLabel
The development of bladder tum ...... ma of the upper urinary tract.
@en
The development of bladder tum ...... ma of the upper urinary tract.
@nl
P2093
P356
P1433
P1476
The development of bladder tum ...... ma of the upper urinary tract.
@en
P2093
Chao-Cheng Huang
Chih-Hsiung Kang
Hwei-Ho Hsieh
Joseph W Yang
Kenneth Shu
Po-Huang Chiang
Tsan-Jung Yu
Yow-Ling Shiue
P304
P356
10.1002/CNCR.11691
P407
P577
2003-10-01T00:00:00Z